Literature DB >> 16570346

Psychological impact of chronic hepatitis C: comparison with other stressful life events and chronic diseases.

Laurent Castera1, Aymery Constant, Pierre-Henri Bernard, Victor de Ledinghen, Patrice Couzigou.   

Abstract

AIM: To examine the psychological impact of chronic hepatitis C (CHC) diagnosis in a large cohort of CHC patients as compared with other stressful life events and chronic diseases carrying a risk of life-threatening complications.
METHODS: One hundred and eighty-five outpatients with compensated CHC were asked to self-grade, using a 100-mm visual analogue scale (VAS), the degree of stress caused by the learning of CHC diagnosis and the perceived severity of their disease. Diagnosis-related stress was compared to four other stressful life events and perceived CHC severity was compared to four other common chronic diseases.
RESULTS: Learning of CHC diagnosis was considered a major stressful event (mean+/-SD scores: 72+/-25), significantly less than death of a loved-one (89+/-13, P<0.0001) and divorce (78+/-23, P<0.007), but more than job dismissal (68+/-30, P<0.04) and home removal (26+/-24, P<0.0001). CHC was considered a severe disease (74+/-19), after AIDS (94+/-08, P<0.001) and cancer (91+/-11, P<0.001), but before diabetes (66+/-23, P<0.001) and hypertension (62+/-20, P<0.001). Perceived CHC severity was not related to the actual severity of liver disease, assessed according to Metavir fibrosis score. In multivariate analysis, diagnosis-related stress was related to perceived disease severity (P<0.001), trait anxiety (P<0.001) and infection through blood transfusion (P<0.001).
CONCLUSION: Our results show the considerable psychological and emotional burden that a diagnosis of CHC represents, even in the absence of significant liver disease. They should be taken into account when announcing a diagnosis of CHC in order to reduce its negative effects.

Entities:  

Mesh:

Year:  2006        PMID: 16570346      PMCID: PMC4124286          DOI: 10.3748/wjg.v12.i10.1545

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  36 in total

Review 1.  Hepatitis C, interferon alfa, and depression.

Authors:  D Zdilar; K Franco-Bronson; N Buchler; J A Locala; Z M Younossi
Journal:  Hepatology       Date:  2000-06       Impact factor: 17.425

2.  Pain experienced during percutaneous liver biopsy.

Authors:  L Castéra; I Nègre; K Samii; C Buffet
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

3.  Psychometric evaluation of the fatigue severity scale for use in chronic hepatitis C.

Authors:  L Kleinman; M W Zodet; Z Hakim; J Aledort; C Barker; K Chan; L Krupp; D Revicki
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

4.  Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease.

Authors:  Daniel M Forton; Howard C Thomas; Christine A Murphy; Joanna M Allsop; Graham R Foster; Janice Main; Keith A Wesnes; Simon D Taylor-Robinson
Journal:  Hepatology       Date:  2002-02       Impact factor: 17.425

5.  The impact of diagnosis of hepatitis C virus on quality of life.

Authors:  A J Rodger; D Jolley; S C Thompson; A Lanigan; N Crofts
Journal:  Hepatology       Date:  1999-11       Impact factor: 17.425

6.  Evidence for a cerebral effect of the hepatitis C virus.

Authors:  D M Forton; J M Allsop; J Main; G R Foster; H C Thomas; S D Taylor-Robinson
Journal:  Lancet       Date:  2001-07-07       Impact factor: 79.321

7.  Emotional distress in chronic hepatitis C patients not receiving antiviral therapy.

Authors:  Robert J Fontana; Khozema B Hussain; Steven M Schwartz; Cheryl A Moyer; Grace L Su; Anna S F Lok
Journal:  J Hepatol       Date:  2002-03       Impact factor: 25.083

8.  Emotional state, coping styles, and somatic variables in patients with chronic hepatitis C.

Authors:  M R Kraus; A Schäfer; H Csef; M Scheurlen; H Faller
Journal:  Psychosomatics       Date:  2000 Sep-Oct       Impact factor: 2.386

9.  Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to interferon therapy. The GEMHEP.

Authors:  M Martinot-Peignoux; F Roudot-Thoraval; I Mendel; J Coste; J Izopet; G Duverlie; C Payan; J M Pawlotsky; C Defer; M Bogard; V Gerolami; P Halfon; Y Buisson; B Fouqueray; P Loiseau; J Lamoril; J J Lefrere; P Marcellin
Journal:  J Viral Hepat       Date:  1999-11       Impact factor: 3.728

10.  Depression, fatigue, and functional disability in patients with chronic hepatitis C.

Authors:  M M Dwight; K V Kowdley; J E Russo; P S Ciechanowski; A M Larson; W J Katon
Journal:  J Psychosom Res       Date:  2000-11       Impact factor: 3.006

View more
  10 in total

Review 1.  The psyche and the gut.

Authors:  Paul Enck; Ute Martens; Sibylle Klosterhalfen
Journal:  World J Gastroenterol       Date:  2007-07-07       Impact factor: 5.742

2.  Links between private habits, psychological stress and brain cancer: a case-control pilot study in France.

Authors:  Cécilia Cabaniols; Roch Giorgi; Olivier Chinot; Nabila Ferahta; Valérie Spinelli; Philippe Alla; Maryline Barrie; Marie-Pascale Lehucher-Michel
Journal:  J Neurooncol       Date:  2010-09-11       Impact factor: 4.130

3.  HCV Cure and Cannabis Abstinence Facilitate Tobacco Smoking Quit Attempts in HIV-HCV Co-Infected Patients (ANRS CO13 HEPAVIH Cohort Study).

Authors:  Tangui Barré; Patrick Mercié; Fabienne Marcellin; Laure Esterle; Claudine Duvivier; Elina Teicher; Morgane Bureau; Julie Chas; Dominique Salmon-Céron; Philippe Sogni; Maria Patrizia Carrieri; Linda Wittkop; Camelia Protopopescu
Journal:  AIDS Behav       Date:  2021-04-27

4.  Cost-effectiveness of hepatitis C treatment for patients in early stages of liver disease.

Authors:  Andrew J Leidner; Harrell W Chesson; Fujie Xu; John W Ward; Philip R Spradling; Scott D Holmberg
Journal:  Hepatology       Date:  2015-03-16       Impact factor: 17.425

5.  Perceived Stress in Hepatitis C Virus Infected Patients under the DAA-Based Therapy.

Authors:  Claudia Monica Danilescu; Mihaela Ionescu; Daniela Larisa Sandulescu; Mihail Cristian Pirlog; Costin Teodor Streba; Ion Rogoveanu
Journal:  Diagnostics (Basel)       Date:  2022-05-09

6.  Uncertainty, symptoms, and quality of life in persons with chronic hepatitis C.

Authors:  Donald E Bailey; Lawrence Landerman; Julie Barroso; Patricia Bixby; Merle H Mishel; Andrew J Muir; Lisa Strickland; Elizabeth Clipp
Journal:  Psychosomatics       Date:  2009 Mar-Apr       Impact factor: 2.386

7.  Perceived risk for severe outcomes and drinking status among drug users with HIV and Hepatitis C Virus (HCV).

Authors:  Jennifer C Elliott; Deborah S Hasin; Don C Des Jarlais
Journal:  Addict Behav       Date:  2016-06-29       Impact factor: 3.913

8.  Long-term effects of treatment and response in patients with chronic hepatitis C on quality of life. An international, multicenter, randomized, controlled study.

Authors:  Geert Bezemer; Arthur R Van Gool; Elke Verheij-Hart; Bettina E Hansen; Yoav Lurie; Juan I Esteban; Martin Lagging; Francesco Negro; Stefan Zeuzem; Carlo Ferrari; Jean-Michel Pawlotsky; Avidan U Neumann; Solko W Schalm; Robert J de Knegt
Journal:  BMC Gastroenterol       Date:  2012-01-31       Impact factor: 3.067

9.  Psychological Reactions among Patients with Chronic Hepatitis B: a Qualitative Study.

Authors:  Leila Valizadeh; Vahid Zamanzadeh; Reza Negarandeh; Farhad Zamani; Angela Hamidia; Ali Zabihi
Journal:  J Caring Sci       Date:  2016-03-01

Review 10.  The ongoing impacts of hepatitis c--a systematic narrative review of the literature.

Authors:  Emma R Miller; Stephen McNally; Jack Wallace; Marisa Schlichthorst
Journal:  BMC Public Health       Date:  2012-08-18       Impact factor: 3.295

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.